Harmony Biosciences acquires Epygenix Therapeutics for $35 million in cash; Pharma’s corporate reputation drops post-COVID; Walmart to close 51 of its health clinics.
Pharma’s corporate reputation begins to slide following COVID surge
As a result of its strong topline performance, Eli Lilly raised its full year revenue guidance by $2 billion to the range of $42.4 billion to $43.6 billion.
Five things for pharma marketers to know for Tuesday morning
Prime Medicine receives FDA approval to launch first prime editing human trial; Regeneron and Sanofi roll out latest Dupixent campaign for allergy season; FDA unveils new rule to strengthen oversight over laboratory medical tests.
Ono Pharmaceutical acquires Deciphera Pharmaceuticals for $2.4B